1. New prediction tools and treatment for ACS patients with plaque erosion
- Author
-
Rocco Vergallo, Filippo Crea, and Ik-Kyung Jang
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Acute coronary syndrome ,Tailored therapy ,Autopsy ,Prediction tools ,030204 cardiovascular system & hematology ,Plaque erosion ,Coronary Angiography ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,In patient ,Acute Coronary Syndrome ,Optical coherence tomography ,business.industry ,Precision medicine ,Plaque rupture ,Thrombosis ,Limiting ,medicine.disease ,Coronary Vessels ,Plaque, Atherosclerotic ,030104 developmental biology ,Settore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARE ,Stents ,Radiology ,Cardiology and Cardiovascular Medicine ,business ,Tomography, Optical Coherence - Abstract
For decades, we have known from autopsy observations that the proximate cause of the majority of acute coronary syndromes ( ACS) is occlusive thrombosis generated by plaque rupture or, less frequently, superficial erosion. Patients with ACS caused by plaque erosion seem to have a better long-term prognosis compared to those with plaque rupture, and may be stabilized by dual antiplatelet therapy without the need for stenting in a non-trivial proportion of cases, limiting the expenses and potential complications of invasive procedures. The accurate prediction of plaque erosion and the identification of specific biomarkers that could be used at the point-of-care without the need of invasive imaging would take us a step closer to the holy grail of precision medicine in patients with ACS.
- Published
- 2021